Simplex Trading
OBIO icon

Simplex Trading’s Orchestra BioMed OBIO Stock Holding History

Simplex Trading’s Portfolio OBIO Stock Details OBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.6K Buy
2,500
+800
+47% +$3.41K ﹤0.01% 7311
2025
Q4 		$7.05K Buy
+1,700
New +$6.86K ﹤0.01% 7218

Other funds holding OBIO

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Simplex Trading's OBIO Position: Q1 2026 in Review

Simplex Trading opened a new position in Orchestra BioMed (OBIO) in Q1 2026: 2,381 shares worth $10.1K. The stake represents ﹤0.01% of the portfolio and ranks #7350 among its holdings. This is a return to the name: Simplex Trading previously reported a position in OBIO as recently as Q3 2025.

Simplex Trading first reported a position in OBIO in Q3 2025 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold OBIO as of Q1 2026.

  • Simplex Trading held 2,381 shares of Orchestra BioMed worth $10.1K as of Q1 2026.
  • Orchestra BioMed was a new Simplex Trading position in Q1 2026.
  • Orchestra BioMed made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7350 holding.
  • Simplex Trading first reported a position in Orchestra BioMed in Q3 2025 and has held it in 2 quarters since.
  • 65 funds tracked by Wall St. Rank held Orchestra BioMed as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.